Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand

BACKGROUND: The national Human Papillomavirus (HPV) Immunisation Programme in New Zealand was introduced in 2008, and involves routine vaccination of girls 12–13 years with a catch-up for females aged up to 19 years. The aims of this study were to measure the pre-vaccination prevalence of oncogenic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Simonella, Leonardo M, Lewis, Hazel, Smith, Megan, Neal, Harold, Bromhead, Collette, Canfell, Karen
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607885/
https://ncbi.nlm.nih.gov/pubmed/23452957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-13-114
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires